Skip to main content

Table 1 Baseline characteristics of all patients with non-metastatic bladder cancer and patients who died according to the time of death after diagnosis

From: Short-term mortality risks among patients with non-metastatic bladder cancer

   Timing of deaths after diagnosis
All Deaths < 1 Year 1–3 Years
Characteristic Total No. of Patients No. of Patients (%) Mean Age at Death, y No. of Patients (%) Mean Age at Death, y No. of Patients (%) Mean Age at Death, y
Overall 24,074 4,179 (100) 77.93 2,289 (54.8) 78.49 1,890 (45.2) 77.25
Age at diagnosis, y
 0–49 1,037 59 (100) 45.9 31 (52.5) 45.31 28 (47.5) 46.56
 50–64 6,394 649 (100) 60.49 303 (46.7) 60.13 346 (53.3) 60.81
  > 64 16,643 3,471 (100) 81.73 1,955 (56.3) 81.86 1,516 (43.7) 81.57
Race
 White 21,432 3,639 (100) 78.22 1,991 (54.7) 78.71 1,648 (45.3) 77.64
 Black 1,352 306 (100) 73.35 171 (55.9) 74.95 135 (44.1) 71.33
 Asian or Pacific Islander 1,201 206 (100) 79.98 108 (52.4) 80.98 98 (47.6) 78.87
 American Indian/Alaska Native 89 28 (100) 74.59 19 (67.9) 73.21 9 (32.1) 77.51
Disease stage
 In situ 12,940 935 (100) 80.25 403 (43.1) 80.32 532 (56.9) 80.20
 Localized 8,574 2,051 (100) 79.26 1,154 (56.3) 79.91 897 (43.7) 78.41
 Regional 1,814 839 (100) 72.56 496 (59.1) 74.26 343 (40.9) 70.11
Histological grade
 Grade I 1,970 161 (100) 79.8 63 (39.1) 78.89 98 (60.9) 80.39
 Grade II 6,232 447 (100) 79.07 214 (47.9) 79.18 233 (52.1) 78.97
 Grade III 2,278 615 (100) 77.36 357 (58.0) 77.96 258 (42.0) 76.52
 Grade IV 9,598 2,244 (100) 76.85 1,236 (55.1) 77.58 1,008 (44.9) 75.96
Cancer-directed surgery
 Yes 22,699 3,739 (100) 77.58 1,996 (53.4) 78.13 1,743 (46.6) 76.95
Radiotherapy
 Yes 1,000 477 (100) 78.69 259 (54.3) 79.34 218 (45.7) 77.92
Chemotherapy
 Yes 7,186 1,290 (100) 73.18 590 (45.7) 73.62 700 (54.3) 72.81
\